|
Interleukin 2 subcutaneous injection Clinical Trials
2 actively recruiting trials
Pipeline
Phase 1: 2
Top Sponsors
- Hangzhou Huasai Biomedicine Co., Ltd.2
Indications
- Cancer2
- Clear Cell Renal Cell Carcinoma1
- Advanced NSCLC1
- Lung Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.